We are excited for Falcons' Fortunes pitch competition tomorrow! Looking forward to learning about 6 Ontario-made breakthrough cancer innovations. Here are 3 of the startups:

AI + quantum computing are redefining life sciences. How can investors stay ahead? Join us April 10 for a webinar with top investors & experts, presented with @biotecanada. Register now: us02web.zoom.us/webinar/regist…

ICYMI The winner of Falcons' Fortunes 2025 was Dr. Wael Hanna, co-founder of NodeAI Diagnostics. The Audience Choice Award went to Ibukun Elebute, co-founder of CELLECT Laboratories. Congratulations! facit.ca/news/falcons-f…

Last call for Prospects funding for early stage innovations solving cancer. Open to start-ups and research institutes in Ontario aiming to commercialize intellectual property related to cancer. Apply by March 31: facit.ca/funds

Strategic investment in life sciences can help us develop homegrown IP that’s resilient to tariffs—and build a more stable, self-sustaining economy. Read more from Christine Williams, Acting President of Ontario Institute for Cancer Research (OICR) and David O’Neill, President of FACIT

Made-in-Canada Life Sciences are an Antidote to US Trade War via @futureconomy thefutureeconomy.ca/op-eds/made-in…

FACIT portfolio company, Radiant Biotherapeutics, profiled in BioCentury. Learn about their innovative multi-specific antibody platform to tackle cancer. radiantbio.com

Nominations for the 2023-24 Minister’s Awards of Excellence are still OPEN! Help us shine a light on Ontario’s best by nominating someone who’s getting it done in Ontario’s postsecondary system! Nominations close Friday May 23. Nominate today 👉 bit.ly/43gsix4

🇨🇦Canada has led in medical breakthroughs, yet foreign companies continue to capitalize on our innovations. Investing in Canadian biotech fuels innovation, strengthens our economy & ensures life-changing advancements benefit Canadians first. 🔖thefutureeconomy.ca/op-eds/the-tim…

Pleased to visit the Ontario Institute for Cancer Research last week to tour their state-of-the-art research facilities. Our government is proud to support OICR’s groundbreaking work to diagnosis and treat cancer with life-saving, made-in-Ontario treatments.

Ontario is investing $6.5 million through the Life Sciences Innovation Fund to help 13 companies develop and launch made-in-Ontario medical innovations and health-care solutions. Learn more: news.ontario.ca/en/release/100… Ontario Centre of Innovation (OCI) #ONBudget2025

Despite their innovation & leadership, women-led companies still face barriers when it comes to securing funding & support. The #OBIO Women in Health Initiative Seed Program is breaking barriers for women-led companies with funding up to $10K, coaching & more. Apply by Aug 29!

We're delighted to launch the Health Commercialization Access Program designed to support early-stage life sciences and health tech companies to build a beachhead in Canada and diversify their target markets amid shifting trade dynamics. 🔗 obio.ca/obio-backup/ob…

🎥 Roll out the red carpet! On September 16, we're shining the spotlight on Ontario’s #biotech & #healthtech stars. Join us at Blakes for an evening of connection, recognition, & forward-looking energy with brilliant minds from our #lifesciences & biotech sector.

Do you have an innovation to solve cancer? FACIT is accepting applications for its Prospects Oncology Fund to support early stage innovations. Apply by Sept 30, 2025. See details here: facit.ca/funds/prospect…

Attention Cancer Innovators! Apply for up to $200K Prospects Oncology Fund to support your early stage innovation to solve cancer. Submissions due Tuesday, Sept 30, 2025. facit.ca/funds/prospect…

We’re cutting wait times for life-saving cancer drugs by up to a year, helping patients get the care they need when they need it most.

👋🏽Are you a Canadian company commercializing products and services in therapeutics, medical devices, diagnostics, digital health and health IT? Apply to pitch to global investors at the 2026 #OBIO Investment Summit, to be held next February in Toronto!⏰Apply before Oct 31!

#OBIO is pleased to announce nine women-led companies selected for the third cohort of its Women in Health Initiative (#WiHI) Seed Program. 🎉 Congratulations 20|20 OptimEyes Technologies, Arche Biotech, BLOCK Biosciences, Fibra, Hada Medtech, NodeAI, NuvoBio, Savyn Tech Inc. & Virano!